Literature DB >> 8005157

Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.

H Young1, P Carnochan, J Zweit, J Babich, S Cherry, R Ott.   

Abstract

Copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) (Cu-PTSM) labelled with 62,64Cu is a promising radiotracer for the study of blood flow using positron emission tomography (PET). We have investigated the application of a simple trapped tracer model to measurements of tissue 64Cu-PTSM uptake combined with continuous arterial sampling. A dual-tracer method was used to compare blood flow estimated by 64Cu-PTSM with values derived from measurements using cobalt-57 microspheres in the rat. Prolonged retention of 64Cu-PTSM following intravenous administration was initially confirmed in both normal tissues and tumours. After intraventricular 64Cu-PTSM infusion, cumulative arterial 64Cu activity increased progressively, and after extraction in n-octanol was found to plateau to levels corresponding with those reached following administration of 57Co microspheres. Rapid and species-dependent rates of 64Cu-PTSM decomposition to non-extractable 64Cu complexes were found in rat and human blood in vitro (70% +/- 6% and 43 +/- 5% respectively at 16 min), demonstrating the need for immediate processing of arterial samples. Close agreement was found between blood flow estimated by 64Cu-PTSM and 57Co microsphere methods in tissues of low to moderate flow: muscle (0.01, 0.08, 0.07 ml/min per gram; mean difference, mean 64Cu, mean 57Co), brain (0.09, 0.52, 0.43 ml/min per gram) and kidney (-0.16, 2.29, 2.45 ml/min per gram). Estimates of cardiac output also compared favourably between the two methods (5.7, 59.8, 54.1 ml/min). We conclude that a simple tissue trapping model may be suitable for the derivation of blood flow estimates using 62,64Cu-PTSM, PET imaging and continuous arterial blood sampling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005157     DOI: 10.1007/BF00947969

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.

Authors:  M A Green; C J Mathias; M J Welch; A H McGuire; D Perry; F Fernandez-Rubio; J S Perlmutter; M E Raichle; S R Bergmann
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

2.  Correlation of Cu(PTSM) localization with regional blood flow in the heart and kidney.

Authors:  A J Barnhart; W D Voorhees; M A Green
Journal:  Int J Rad Appl Instrum B       Date:  1989

3.  The performance of a multiwire proportional chamber positron camera for clinical use.

Authors:  P K Marsden; R J Ott; J E Bateman; S R Cherry; M A Flower; S Webb
Journal:  Phys Med Biol       Date:  1989-08       Impact factor: 3.609

4.  Measurement of cardiac output distribution using microspheres. Some practical and theoretical considerations.

Authors:  D J Warren; J G Ledingham
Journal:  Cardiovasc Res       Date:  1974-07       Impact factor: 10.787

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography.

Authors:  M E Shelton; M A Green; C J Mathias; M J Welch; S R Bergmann
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

7.  Simultaneous measurement of total and nutritional coronary blood flow in dogs.

Authors:  A D LeBlanc; R C Riley; R G Robinson
Journal:  Circulation       Date:  1974-02       Impact factor: 29.690

8.  Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography.

Authors:  J Zweit; R Goodall; M Cox; J W Babich; G A Potter; H L Sharma; R J Ott
Journal:  Eur J Nucl Med       Date:  1992

9.  Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.

Authors:  M A Green; D L Klippenstein; J R Tennison
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

10.  Investigation of copper-PTSM as a PET tracer for tumor blood flow.

Authors:  C J Mathias; M J Welch; D J Perry; A H McGuire; X Zhu; J M Connett; M A Green
Journal:  Int J Rad Appl Instrum B       Date:  1991
View more
  4 in total

1.  Future direction of renal positron emission tomography.

Authors:  Zsolt Szabo; Jinsong Xia; William B Mathews; Phillip R Brown
Journal:  Semin Nucl Med       Date:  2006-01       Impact factor: 4.446

2.  Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

Authors:  David W Dietz; Farrokh Dehdashti; Perry W Grigsby; Robert S Malyapa; Robert J Myerson; Joel Picus; Jon Ritter; Jason S Lewis; Michael J Welch; Barry A Siegel
Journal:  Dis Colon Rectum       Date:  2008-08-06       Impact factor: 4.585

3.  In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.

Authors:  Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

4.  Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.

Authors:  Simone Alidori; Giancarlo Gioia Lobbia; Grazia Papini; Maura Pellei; Marina Porchia; Fiorenzo Refosco; Francesco Tisato; Jason S Lewis; Carlo Santini
Journal:  J Biol Inorg Chem       Date:  2007-11-27       Impact factor: 3.358

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.